Our results highlight the importance of telomerase in the regulation of angiogenesis and suggest that the inhibition of VEGF in combination with telomerase, PI3K/AKT, or HIF-1α inhibitors could improve tumor cell response to VEGF inhibitors and could decrease resistance mechanisms related to anti-VEGF treatments. The gene discussed is AKT1; the disease is neoplasm.